Edition:
United Kingdom

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.19USD
20 Jul 2018
Change (% chg)

-- (--)
Prev Close
$0.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
96,257
52-wk High
$2.63
52-wk Low
$0.17

Latest Key Developments (Source: Significant Developments)

Immune Pharma Presents Positive Results From Phase 2 Trial Of Bullous Pemphigoid Treatment
Tuesday, 15 May 2018 

May 15 (Reuters) - Immune Pharmaceuticals Inc ::IMMUNE PHARMACEUTICALS PRESENTS UPDATED POSITIVE RESULTS FROM PHASE 2 TRIAL OF BERTILIMUMAB IN BULLOUS PEMPHIGOID.IMMUNE PHARMACEUTICALS INC - POSITIVE DATA SUPPORT COMPANY'S PLANS TO COMMENCE PIVOTAL REGISTRATION STUDY IN 2019.IMMUNE PHARMACEUTICALS INC - RESULTS FROM ALL SUBJECTS CONFIRM "EXCELLENT" SAFETY AND TOLERABILITY.  Full Article

Immune Pharmaceuticals reports Q3 results
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Immune Pharmaceuticals Inc :Immune Pharmaceuticals announces third quarter 2017 financial results and provides a corporate update.Immune Pharmaceuticals Inc - ‍Company recorded no revenue for three-month periods ended September 30, 2017 and 2016​.  Full Article

Immune Pharmac prices $18 mln public offering
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Immune Pharmaceuticals Inc :Immune Pharmaceuticals Inc announces pricing of $18,000,000 public offering of convertible preferred stock and warrants.Immune Pharmaceuticals Inc - ‍offering will be comprised of units, priced at a public offering price of $1,000 per unit​.  Full Article

Immune Pharmaceuticals Q2 loss per share $0.13
Tuesday, 16 Aug 2016 

Immune Pharmaceuticals Inc : Q2 loss per share $0.13 .Immune Pharmaceuticals provides business and research and development update and announces second quarter 2016 financial results.  Full Article

BRIEF-Immune Pharmaceuticals Provides Pipeline Update

* IMMUNE PHARMACEUTICALS INC - CONTINUE DISCUSSIONS WITH PARTIES POTENTIALLY INTERESTED IN ACQUIRING CERTAIN OF CYTOVIA'S ASSETS